Cortexyme cortexyme.com


Public list: Pharma Startups (6570) Neuroscience Startups (947)

Cortexyme is developing therapeutics based on data supporting a new theory of the cause of Alzheimer's and other degenerative disorders. Cortexyme is targeting a specific, undisclosed pathogen tied to neurodegeneration and beta amyloid production.

Cortexyme is developing therapeutics based on data supporting a new theory of the cause of Alzheimer's and other degenerative disorders. Cortexyme is targeting a specific, undisclosed pathogen tied to neurodegeneration and beta amyloid production.

Company (IPO / Went public)

Phone: 415-279-3644

Fax:

269 East Grand Ave.

South San Francisco, 94080
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cortexyme $100M May 9, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cortexyme Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Breakout VenturesVenture CapitalSan Francisco, California, United StatesSeries B
Breakout LabsIncubator/AcceleratorSan Francisco, California, United StatesGrant
Dolby Family VenturesVenture CapitalSan Francisco, California, United StatesSeries B, Seed VC
Huizenga Capital ManagementOtherSeries B
Epiq CapitalVenture CapitalMumbai, IndiaSeries B
See all 13 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Inhibitors of lysine gingipain Oct 05, 2015 Sep 12, 2017 Patent
Inhibitors of lysine gingipain Aug 22, 2017 Application
Methods of use for therapeutics targeting the pathogen porphyromonas gingivalis Apr 29, 2015 Application